OR WAIT null SECS
February 06, 2020
The new facility includes six classified environment rooms with space to expand.
February 05, 2020
Catalent builds on its investment in cell and gene therapy development and manufacturing with the acquisition of MaSTherCell Global.
The knockout CHO K1 cell line will be used to support biotherapeutic R&D across a range of therapeutic indications.
West Pharmaceutical Services will be showcasing various new pharmaceutical containment and closure offerings at Pharmapack from Feb. 5–6 in Paris, France.
February 03, 2020
In replacing the retiring Paul Hegwood, Ricci Whitlow will oversee global clinical trial operations.
January 31, 2020
The partners will collaborate on developing scale-up chip-based technology to enable commercial-scale production of a third-generation DNA synthesis platform.
The license gives Daiichi Sankyo access to ERS Genomics’ genome-editing technology for internal R&D initiatives.
The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.
Otsuka will use PhoreMost’s phenotypic screening platform to identify new targets for drug development, with a focus on gene therapy.
January 30, 2020
The company announced it will be unveiling a new name, Jones Healthcare Group, and a new corporate logo as it celebrates 100 years in the health and wellness markets.